IR-News

AUSSENDER



HOCHDORF Holding Ltd
Ansprechpartner: Dr. Christoph Hug
Tel.: +41 41 914 65 62
E-Mail: christoph.hug@hochdorf.com

FRüHERE MELDUNGEN

21.08.2019 - 18:30 | HOCHDORF Holding AG
21.08.2019 - 18:30 | HOCHDORF Holding Ltd
20.08.2019 - 07:00 | HOCHDORF Holding AG
20.08.2019 - 07:00 | HOCHDORF Holding Ltd
07.08.2019 - 17:45 | HOCHDORF Holding AG

Mediabox

pta20190826032
Announcement according to SIX adhoc publication article 53 KR

HOCHDORF Holding Ltd: New CEO at Pharmalys Laboratories SA

Dr Peter Pfeilschifter assumes role of CEO at Pharmalys Laboratories SA


Hochdorf (pta032/26.08.2019/17:45) - Dr Peter Pfeilschifter, currently Chairman of the Board of Directors at Pharmalys Laboratories SA, is to take on the role of CEO at Pharmalys Laboratories SA with immediate effect. Dr Pfeilschifter will take responsibility for the operational business in the next few days. The interim CEO of the HOCHDORF Group will be supported in this additional role by Baby Care team employees at HOCHDORF Swiss Nutrition Ltd. The new CEO appointment became necessary when Amir Mechria resigned from all his responsibilities at Pharmalys Laboratories SA. This development means that HOCHDORF assumes responsibility for the operational business of Pharmalys Laboratories SA.

(end)
emitter: HOCHDORF Holding Ltd
Siedereistrasse 9
6281 Hochdorf
Switzerland
contact person: Dr. Christoph Hug
phone: +41 41 914 65 62
e-mail: christoph.hug@hochdorf.com
website: www.hochdorf.com/
stock exchanges: listed in SIX Swiss Exchange
ISIN(s): CH0024666528 (share)
|
|
98.209 Abonnenten
|
175.712 Meldungen
|
71.287 Pressefotos

BUSINESS

Top